These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14552090)

  • 1. Advanced glycation in uraemic toxicity.
    van Ypersele de Strihou C
    EDTNA ERCA J; 2003; 29(3):148-50. PubMed ID: 14552090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of non-enzymatic biochemistry in uremia, diabetes, and atherosclerosis ("carbonyl stress").
    Miyata T
    Bull Mem Acad R Med Belg; 2002; 157(3-4):189-96; discussion 196-8. PubMed ID: 12508715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation and lipoxidation end products: reactive carbonyl compounds-related uraemic toxicity.
    Miyata T; Saito A; Kurokawa K; van Ypersele de Strihou C
    Nephrol Dial Transplant; 2001; 16 Suppl 4():8-11. PubMed ID: 11402090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress").
    Miyata T; Sugiyama S; Saito A; Kurokawa K
    Kidney Int Suppl; 2001 Feb; 78():S25-31. PubMed ID: 11168978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds.
    Miyata T; Horie K; Ueda Y; Fujita Y; Izuhara Y; Hirano H; Uchida K; Saito A; van Ypersele de Strihou C; Kurokawa K
    Kidney Int; 2000 Jul; 58(1):425-35. PubMed ID: 10886591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound mishandling of protein glycation degradation products in uremia and dialysis.
    Agalou S; Ahmed N; Babaei-Jadidi R; Dawnay A; Thornalley PJ
    J Am Soc Nephrol; 2005 May; 16(5):1471-85. PubMed ID: 15800128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms for the formation of glycoxidation products in end-stage renal disease.
    Weiss MF; Erhard P; Kader-Attia FA; Wu YC; Deoreo PB; Araki A; Glomb MA; Monnier VM
    Kidney Int; 2000 Jun; 57(6):2571-85. PubMed ID: 10844627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced glycation end products in renal failure.
    Thornalley PJ
    J Ren Nutr; 2006 Jul; 16(3):178-84. PubMed ID: 16825015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure.
    Makita Z; Bucala R; Rayfield EJ; Friedman EA; Kaufman AM; Korbet SM; Barth RH; Winston JA; Fuh H; Manogue KR
    Lancet; 1994 Jun; 343(8912):1519-22. PubMed ID: 7911868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure.
    Miyata T; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Nephrol Dial Transplant; 1997 Feb; 12(2):255-8. PubMed ID: 9132640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relevance of oxidative and carbonyl stress to long-term uremic complications.
    Miyata T; Kurokawa K; van Ypersele de Strihou C
    Kidney Int Suppl; 2000 Aug; 76():S120-5. PubMed ID: 10936808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced glycation end products in uremia.
    Henle T; Miyata T
    Adv Ren Replace Ther; 2003 Oct; 10(4):321-31. PubMed ID: 14681861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Carbonyl stress' and dialysis-related amyloidosis.
    Miyata T; Ueda Y; Saito A; Kurokawa K
    Nephrol Dial Transplant; 2000; 15 Suppl 1():25-8. PubMed ID: 10737163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible significance of advanced glycation end products in serum in end-stage renal disease and in late complications of diabetes.
    Dolhofer-Bliesener R; Lechner B; Gerbitz KD
    Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):355-61. PubMed ID: 8704053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of carbonyl stress in long-term uraemic complications.
    Wada T; Miyata T; Kurokawa K
    Nephrol Dial Transplant; 1999; 14 Suppl 1():79-81. PubMed ID: 10048461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products in clinical nephrology.
    Kalousová M; Zima T; Tesar V; Stípek S; Sulková S
    Kidney Blood Press Res; 2004; 27(1):18-28. PubMed ID: 14679311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal clearance of glycation adducts: anti-glycation defence in uraemia and dialysis.
    Dawnay A
    Biochem Soc Trans; 2003 Dec; 31(Pt 6):1386-9. PubMed ID: 14641069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathogenesis and consequences of AGE formation in uraemia and its treatment.
    Dawnay A; Millar DJ
    Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1081-94. PubMed ID: 9846890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological modulation of AGEs: a unique role for redox-active metal ions.
    Weiss MF; Saxena AK; Monnier VM
    Perit Dial Int; 1999; 19 Suppl 2():S62-7. PubMed ID: 10406496
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications.
    Miyata T; van Ypersele de Strihou C; Kurokawa K; Baynes JW
    Kidney Int; 1999 Feb; 55(2):389-99. PubMed ID: 9987064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.